Research Overview: Matofin 850 Sanovel
Matofin 850 is a metformin hydrochloride pharmaceutical preparation manufactured by Sanovel, containing 850mg of active compound per tablet. This biguanide derivative represents a cornerstone compound in metabolic research, extensively studied for its effects on cellular glucose utilisation and AMPK pathway activation. Researchers investigating metabolic disorders frequently examine metformin’s mechanism of action through inhibition of hepatic gluconeogenesis and enhancement of peripheral glucose uptake. The compound’s ability to modulate cellular energy sensing pathways makes it valuable for studying mitochondrial function and metabolic homeostasis. At Stroid UK Shop, we supply pharmaceutical-grade metformin formulations exclusively for laboratory research applications.
Research Applications
Laboratory studies utilise metformin hydrochloride to investigate multiple metabolic pathways and cellular mechanisms. Research applications include examining AMPK-dependent signalling cascades, studying insulin sensitivity modulation in cell culture models, and analysing effects on mitochondrial respiratory chain function. Scientists frequently study metformin’s role in inhibiting complex I of the electron transport chain, leading to increased AMP:ATP ratios and subsequent AMPK activation. The compound serves as a valuable research tool for investigating autophagy mechanisms, mTOR pathway suppression, and cellular stress responses. Researchers within our metformin research category often combine these investigations with studies using compounds from our SARMs collection and peptides range to examine metabolic interactions.
Product Specifications
| Parameter | Value |
|---|---|
| Active Ingredient | Metformin Hydrochloride |
| Strength | 850mg per tablet |
| Manufacturer | Sanovel |
| CAS Number | 1115-70-4 |
| Molecular Formula | C₄H₁₁N₅·HCl |
| Molecular Weight | 165.63 g/mol |
| Storage Conditions | Room temperature, dry environment |
| Research Grade | Pharmaceutical standard |
Research Compliance Statement
Matofin 850 is supplied strictly for in-vitro research purposes only. This product is not intended for human consumption, therapeutic use, or any clinical applications. Researchers must ensure appropriate laboratory protocols and safety measures when handling this compound. All studies should be conducted within approved research facilities with proper institutional oversight and ethical clearance where applicable.
